Bicocca Open Archive

Logo unimib boa
AROLDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.340
AS - Asia 3.116
EU - Europa 2.010
SA - Sud America 458
AF - Africa 84
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.233
VN - Vietnam 896
SG - Singapore 846
IT - Italia 766
CN - Cina 586
BR - Brasile 345
HK - Hong Kong 310
RU - Federazione Russa 267
DE - Germania 230
IE - Irlanda 134
SE - Svezia 130
GB - Regno Unito 94
FR - Francia 91
IN - India 87
BD - Bangladesh 58
KR - Corea 58
ES - Italia 51
FI - Finlandia 50
CA - Canada 43
PL - Polonia 43
AR - Argentina 42
ID - Indonesia 39
NL - Olanda 38
MX - Messico 36
ZA - Sudafrica 35
IQ - Iraq 34
TR - Turchia 29
JP - Giappone 26
CH - Svizzera 24
PH - Filippine 24
PK - Pakistan 21
AT - Austria 20
SA - Arabia Saudita 19
UA - Ucraina 19
CO - Colombia 16
VE - Venezuela 16
UZ - Uzbekistan 15
EC - Ecuador 13
EG - Egitto 11
CZ - Repubblica Ceca 9
LT - Lituania 9
AU - Australia 8
CL - Cile 8
KE - Kenya 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 7
PY - Paraguay 7
CR - Costa Rica 6
IR - Iran 6
MA - Marocco 6
DO - Repubblica Dominicana 5
IL - Israele 5
NO - Norvegia 5
NP - Nepal 5
AZ - Azerbaigian 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
UY - Uruguay 4
BG - Bulgaria 3
JO - Giordania 3
MU - Mauritius 3
MY - Malesia 3
NI - Nicaragua 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZW - Zimbabwe 2
AL - Albania 1
BE - Belgio 1
FJ - Figi 1
GD - Grenada 1
GR - Grecia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 9.009
Salva come PNG Salva come JPEG
Città #
Ann Arbor 545
Singapore 474
Ashburn 390
San Jose 325
Hong Kong 279
Ho Chi Minh City 265
Milan 256
Hanoi 253
Dallas 208
Los Angeles 151
New York 138
Dublin 134
Frankfurt am Main 131
Hefei 119
Chandler 86
Beijing 84
Fairfield 71
Santa Clara 68
Wilmington 68
Chicago 62
Woodbridge 62
Seoul 56
Houston 48
Council Bluffs 41
The Dalles 40
Lauterbourg 39
São Paulo 38
Seattle 36
Haiphong 34
Shanghai 32
Jakarta 30
Munich 30
Buffalo 29
Warsaw 29
Johannesburg 27
Kent 26
Rome 26
Orem 25
Princeton 24
Tokyo 24
Biên Hòa 22
Poplar 21
Cambridge 20
Helsinki 20
Monza 20
Lissone 19
Moscow 19
Zurich 19
Da Nang 18
Atlanta 17
Chennai 17
Guangzhou 17
Nuremberg 17
Thái Nguyên 17
Turku 17
Ha Long 16
Hải Dương 16
Sesto San Giovanni 16
Baghdad 15
Ninh Bình 15
Desio 14
London 14
Montreal 14
Romola 14
Stockholm 14
Amsterdam 13
Denver 13
Phoenix 13
Rio de Janeiro 13
Seveso 13
Toronto 13
Turin 13
Lawrence 12
Quận Bình Thạnh 12
Tashkent 12
Altamura 11
Brooklyn 11
Bắc Ninh 11
Lappeenranta 11
Bologna 10
Can Tho 10
Mexico City 10
Riyadh 10
Salt Lake City 10
Querétaro 9
Bogotá 8
Bắc Giang 8
Como 8
Curitiba 8
Dhaka 8
Dong Ket 8
Erbil 8
Jacksonville 8
Lesmo 8
Quận Một 8
Quận Phú Nhuận 8
San Diego 8
Tianjin 8
Ankara 7
Barnet 7
Totale 5.579
Salva come PNG Salva come JPEG
Nome #
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 445
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 415
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 375
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 371
Idiopathic erythrocytosis: a germline disease? 368
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 360
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 332
Chronic myeloid leukemia: Second-line drugs of choice 322
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 320
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 316
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 307
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 297
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 263
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 259
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 258
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 252
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 247
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 245
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 244
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 231
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 230
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 227
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 224
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 221
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 221
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 217
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 216
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 213
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 209
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 191
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 172
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 134
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 125
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 115
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 104
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 102
Totale 9.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/20251.883 56 141 88 76 119 88 113 69 170 323 213 427
2025/20265.056 887 456 456 708 495 222 769 223 340 462 38 0
Totale 9.148